drugIndia
Cart
Mydekla 60 Tablet

Mydekla 60 Tablet

Daclatasvir (60mg)

Mylan Pharmaceuticals Pvt Ltd - A Viatris Company
hepatitis C
4204.005255.0020% OFF
In Stock
1
Safe & Secure
Easy Returns
24/7 Support
Delivery
drugIndia verified
Save 33%
Best Alternative100% Match

Natdac 60 Tablet

Natco Pharma Ltd

Daclatasvir 60mg
Natdac 60 Tablet

Pack Size

strip of 28 tablets

Price

2800.0020% off
Natdac 60 Tablet is 100% same as Mydekla 60 Tablet
Better ValueSame QualitySame Effectiveness

Save ₹1404

that's 33% off!

composition
  1. Daclatasvir 60mg
Buy Now
4204.0020% OFF
5255.00

About This Medicine

Product description & overview

Mydekla 60 Tablet - Daclatasvir 60mg

Mydekla 60 Tablet, containing the active ingredient Daclatasvir (60mg), is a prescription medication prescribed for the treatment of chronic Hepatitis C Virus (HCV) infections. This single-tablet regimen helps combat the virus by blocking its ability to replicate within the body's cells.

Mydekla 60 Tablet is taken orally and administered once daily for 8 weeks, based on individual patient needs and in accordance with medical guidance. It effectively clears HCV infection, leading to a successful treatment outcome.

Please Note: This medication should only be used under the supervision of a healthcare professional. This description provides general information about Mydekla 60 Tablet and is not a substitute for professional medical advice. Always consult your doctor or pharmacist before taking any medication.

Important: This product may interact with other medications. It's essential to inform your healthcare provider about all existing medications and supplements you are currently taking before initiating this treatment.

Active composition

Daclatasvir 60 mg

About Daclatasvir

Daclatasvir is an antiviral medication used in combination with sofosbuvir to treat chronic hepatitis C infections, specifically genotype 1 or 3. It functions as an NS5A inhibitor, blocking viral replication and reducing the viral load in the liver. This medication is critical for managing hepatitis C, a contagious infection that can lead to severe liver complications. In summary, Daclatasvir is essential for treating chronic hepatitis C infections.

How It Works

Daclatasvir inhibits the NS5A protein of the hepatitis C virus, disrupting the viral replication process and reducing viral load.

Medicine Strength
60 mg

Dosage & How to Use

Dosage information not available. Please consult your doctor or pharmacist.

Safety Advice

Important precautions

Side Effect Occurrence

Based on clinical trials and patient reports.

Overall Tolerance

Most patients tolerate well

Only 2.3% reported effects

Common Side Effects

Headache8%
Nausea5%
Dizziness3%
Fatigue2%
Rash1%
Higher
Lower

Safety Advice

Alcohol

It is not known whether it is safe to consume alcohol with Mydekla 60 Tablet. Please consult your doctor.

High Risk

Pregnancy

Mydekla 60 Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.

Medical Advice

Driving

It is not known whether Mydekla 60 Tablet alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.

Exercise Caution

Liver

Mydekla 60 Tablet is safe to use in patients with liver disease. No dose adjustment of Mydekla 60 Tablet is recommended.

Regular Checkup

Breastfeeding

Mydekla 60 Tablet is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.

Consult Doctor

Kidney

Mydekla 60 Tablet is safe to use in patients with kidney disease. No dose adjustment of Mydekla 60 Tablet is recommended.

Regular Checkup

Customer Reviews

0 reviews for Mydekla 60 Tablet